Effects of Cognitive Dual-Task on Gait in Parkinson's Disease (NCT07540325) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Effects of Cognitive Dual-Task on Gait in Parkinson's Disease
Turkey (Türkiye)30 participantsStarted 2026-04-20
Plain-language summary
The aim of this study is to evaluate gait in individuals diagnosed with PD under tasks involving different cognitive domains, to compare the results with those of age and sex-matched healthy individuals, and to determine which cognitive function has the greatest impact on gait in PD.
Who can participate
Age range
40 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria for Individuals with Parkinson's Disease:
* A clinical diagnosis of Parkinson's Disease confirmed by a neurologist according to the United Kingdom Parkinson's Disease Society Brain Bank diagnostic criteria
* Classified between stages 1 and 3 according to the Modified Hoehn and Yahr Staging Scale
* Aged between 40 and 80 years
* A score of at least 21 on the Montreal Cognitive Assessment (MoCA)
* Ability to walk continuously for at least 10 minutes without interruption and without the use of any assistive walking device
* Having received at least 5 years of formal education
Exclusion Criteria for Individuals with Parkinson's Disease:
* Presence of any neurological disorder other than Parkinson's Disease
* Presence of any cardiopulmonary or musculoskeletal condition that may impair safe ambulation
* A score of ≥10 for anxiety and ≥7 for depression on the Hospital Anxiety and Depression Scale (HADS)
* Presence of visual or auditory impairments that cannot be corrected with assistive devices
Inclusion Criteria for Healthy Individuals:
* Aged between 40 and 80 years
* A score of at least 21 on the Montreal Cognitive Assessment (MoCA)
Exclusion Criteria for Healthy Individuals:
* Presence of any neurological disorder
* Presence of any cardiopulmonary or musculoskeletal condition that may affect safe ambulation
* A score of ≥10 for anxiety and ≥7 for depression on the Hospital Anxiety and Depression Scale (HADS)
* Presence of visual or auditory impairments …
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Global Cognition Assessed by the Montreal Cognitive Assessment
Timeframe: Day 1
2
Language Function Assessed by the Boston Naming Test
Timeframe: Day 1
3
Memory Assessed by the Rey Auditory Verbal Learning Test
Timeframe: Day 1
4
Visuospatial Function Assessed by the Benton Judgment of Line Orientation Test
Timeframe: Day 1
5
Executive Function Assessed by the Stroop Test (Çapa Version)
Timeframe: Day 1
6
Attention Assessed by the Digit Span Test
Timeframe: Day 1
7
Analysis of Spatiotemporal Gait Parameters Under Dual-Task Conditions